« Back
Home /
Ginsenoside Re

Ginsenoside Re

Item no.	TMO-T2872-25mg
Manufacturer	TargetMol
CASRN	52286-59-6
Amount	25mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Purity	0,9912
Citations	1. Nam Y, et al. J Appl Toxicol. 2015 Aug;35(8):927-44.
Smiles	C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2O[C@H]2C[C@]3(C)[C@H](C[C@@H](O)[C@@H]4[C@H](CC[C@@]34C)[C@](C)(CC\C=C(/C)C)O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@]3(C)CC[C@H](O)C(C)(C)[C@H]23)[C@H](O)[C@H](O)[C@H]1O
ECLASS 5.1	32169090
ECLASS 6.1	32169090
ECLASS 8.0	32169090
ECLASS 9.0	32169090
ECLASS 10.0.1	32169090
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	inhibitor, Sanchinoside Re , Ginsenoside B2 , Chikusetsusaponin Ivc , Panaxoside Re
Available
Short Description	Ginsenoside Re may have properties that inhibit or prevent the growth of tumors.
Shipping	cool pack
Storage	-20°
Target names or alias	Sanchinoside Re , Ginsenoside B2 , Chikusetsusaponin Ivc , Panaxoside Re
Molecular Weight	947, 14
Pathway	Metabolism\|\|\|NF-Κb\|\|\|Neuroscience\|\|\|MAPK
Target	Endogenous Metabolite\|\|\|Beta Amyloid\|\|\|JNK\|\|\|NF-κB

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 25mg

available

Delivery expected until 8/9/2024

Express Delivery: Save 4 days

Compare

Add to wishlist

Recommend by mail